Phase II randomized trial of a non-steroidal mouth wash for prevention and treatment of stomatitis in women with hormone receptor positive breast cancer treated with everolimus

por Peddi, Parvin F., Tetef, Merry, Coluzzi, Paul, Arzoo, Karo K., Hu, Eddie H., Berkowitz, Maurice J., Chan, David, Moore, Dennis, Adams, Brad, Wang, Xiaoyan, Hurvitz, Sara A.
Publicado 2020

Phase Ib/II single-arm trial evaluating the combination of everolimus, lapatinib and capecitabine for the treatment of HER2-positive breast cancer with brain metastases (TRIO-US B-...

por Hurvitz, Sara, Singh, Rashi, Adams, Brad, Taguchi, Julie A., Chan, David, Dichmann, Robert A., Castrellon, Aurelio, Hu, Eddie, Berkowitz, Jonathan, Mani, Aruna, DiCarlo, Brian, Callahan, Rena, Smalberg, Ira, Wang, Xiaoyan, Meglar, Ivana, Martinez, Diego, Hobbs, Evthokia, Slamon, Dennis J.
Publicado 2018

Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07)

por Hurvitz, Sara A., Caswell-Jin, Jennifer L., McNamara, Katherine L., Zoeller, Jason J., Bean, Gregory R., Dichmann, Robert, Perez, Alejandra, Patel, Ravindranath, Zehngebot, Lee, Allen, Heather, Bosserman, Linda, DiCarlo, Brian, Kennedy, April, Giuliano, Armando, Calfa, Carmen, Molthrop, David, Mani, Aruna, Chen, Hsiao-Wang, Dering, Judy, Adams, Brad, Kotler, Eran, Press, Michael F., Brugge, Joan S., Curtis, Christina, Slamon, Dennis J.
Publicado 2020